ChilversMcCrea Healthcare, one of the UK’s leading independent providers of urgent care and primary care services to the NHS, has an unrivalled reputation in delivering high quality healthcare; TBSGB ltd, a subsidiary of Europe’s main telemedicine provider with over 20 years experience, has designed Home-Based Telemonitoring Services for CHF and COPD in order to improve quality of care and contain costs to Health Systems by reducing hospital admissions. ChilversMcCreaTBSGB ltd will enhance the capabilities of both businesses in the treatment of CHF and COPD and other conditions in the UK. It represents a tremendous opportunity to deliver life-changing improvements to patients by embracing a proven model to effectively monitor and treat chronic diseases. ChilversMcCrea Healthcare’s and TBSGB’s combined expertise will deliver a range of innovative tools and services for the NHS and the private sector. William Moffit, UK Operations Manager for TBSGB commented that “Several trials and experiences have demonstrated the cost-effectiveness of Telehealth for treating CHF and COPD. Large-scale randomised clinical trials in Europe determined that Telemonitoring services for heart failure patients can reduce hospitalisations and improve patient well being while reducing the overall cost of care.”
The new company will leverage the advantages that technology is bringing to primary care in the UK. The combination of medical expertise with state of the art technology differentiates the company from other suppliers of technology solutions and will provide a complete package to complement and enhance current healthcare provision.
Commenting on the announcement, Dr Sarah Chilvers, Chief Executive of ChilversMcCrea Healthcare, said, "I am delighted to announce the formation of ChilversMcCreaTBSGB Ltd. By working together we are in a position to become the leading independent sector provider of telemedicine services The new company will support Strategic Health Authorities and Primary Care Trusts in monitoring the health of patients with CHF, COPD and other conditions, and provide appropriate interventions to meet their needs, providing patients with an improved, and convenient approach to managing their health and well-being." Professor Nick Bosanquet who joined the Board of TBSGB in early 2006 to develop new services commented: “The NHS faces a powerful series of changes which are going to mean much greater economic pressure on all providers; the formation of this new company provides a very effective model of care whilst addressing the requirements of both healthcare providers and patients alike”.For more information please visit the ChilversMcCrea website at http://www.chilversmccrea.co.uk or telephone Antony Dyson on 0161 277 7693
